PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--Regulatory News:
STENTYS (FR0010949404 — STNT) (Paris:STNT), a medical technology company commercializing the world's first and only Self-Apposing® stent to treat acute myocardial infarction (AMI), today announced that the 2014 SGH tender has awarded more than 1,000 coronary stents to STENTYS.
The SGH Tender is a group purchasing program that serves the Ministries of Health in the six GCC members states: United Arab Emirates, Kingdom of Bahrain, Kingdom of Saudi Arabia, Sultanate of Oman, State of Qatar and State of Kuwait. It is renewed every year for a period of one year.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
